Piskel Kyle
Chief Financial Officer at ADPT
- Sold, on record
- $3.7M
- Dollars the filings state
- Form 4 sales
- 14
- Latest May 18, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ADPTAdaptive Biotechnologies CorpChief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ADPTUnusualNov 28, 2025 2025
Sold 162,820 shares at $19.50 ($3.2M)
Piskel Kyle, Chief Financial Officer
10b5-1 planSold 42.9% of holdings ($7.4M position)216,637 shares left84.4x usual sizeFollows a Form 144Filing
- 2 Form 144 notice ADPTNoticeJan 12, 2026 +45 days
Filed to sell 11,081 shares ($175k)
Piskel Kyle, Officer
10b5-1 plan2.3x usual sizeFiling
- 3 Form 4 sale ADPTRoutineJan 12, 2026 same day
Sold 4,290 shares at $18.00 ($77k)
Piskel Kyle, Chief Financial Officer
10b5-1 planSold 1.9% of holdings ($4M position)216,637 shares left0.9x usual sizeFollows a Form 144Filing
- 4 Form 4 sale ADPTRoutineFeb 4, 2026 +23 days
Sold 2,145 shares at $18.46 ($40k)
Piskel Kyle, Chief Financial Officer
10b5-1 planSold 1% of holdings ($4M position)216,637 shares left0.5x usual sizeFollows a Form 144Filing
- 5 Form 4 sale ADPTUnusualMar 11, 2026 +35 days
Sold 18,672 shares at $13.17 ($246k)
Piskel Kyle, Chief Financial Officer
No 10b5-1 planSold 6.7% of holdings ($3.7M position)259,840 shares left8.7x usual sizeFollows a Form 144Filing
- 6 Form 144 notice ADPTNoticeMar 16, 2026 +5 days
Filed to sell 18,672 shares ($271k)
Piskel Kyle, Officer
No 10b5-1 plan5.8x usual sizeFiling
- 7 Form 144 notice ADPTNoticeMay 15, 2026 +60 days
Filed to sell 3,160 shares ($41k)
Piskel Kyle, Officer
No 10b5-1 plan1x usual sizeFiling
- 8 Form 4 sale ADPTNo planMay 18, 2026 +3 days
Sold 3,115 shares at $13.04 ($41k)
Piskel Kyle, Chief Financial Officer
No 10b5-1 planSold 1.2% of holdings ($3.4M position)256,725 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (18)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 20, 2026 | ADPT | Chief Financial Officer | Form 4 sale | 3,115 | $41k | 1.2% | No plan | SEC |
| May 15, 2026 | May 15, 2026 | ADPT | Officer | Form 144 notice | 3,160 | $41k | Notice | SEC | |
| Mar 16, 2026 | Mar 16, 2026 | ADPT | Officer | Form 144 notice | 18,672 | $271k | Notice | SEC | |
| Mar 11, 2026 | Mar 13, 2026 | ADPT | Chief Financial Officer | Form 4 sale | 18,672 | $246k | 6.7% | Unusual | SEC |
| Feb 4, 2026 | Feb 6, 2026 | ADPT | Chief Financial Officer | Form 4 sale | 2,145 | $40k | 1.0% | Routine | SEC |
| Jan 12, 2026 | Jan 14, 2026 | ADPT | Chief Financial Officer | Form 4 sale | 4,290 | $77k | 1.9% | Routine | SEC |
| Jan 12, 2026 | Jan 12, 2026 | ADPT | Officer | Form 144 notice | 11,081 | $175k | Notice | SEC | |
| Nov 28, 2025 | Dec 2, 2025 | ADPT | Chief Financial Officer | Form 4 sale | 162,820 | $3.2M | 42.9% | Unusual | SEC |
| Nov 28, 2025 | Nov 28, 2025 | ADPT | Officer | Form 144 notice | 162,820 | $3.2M | Notice | SEC | |
| Nov 17, 2025 | Nov 18, 2025 | ADPT | Chief Financial Officer | Form 4 sale | 238 | $3k | 0.1% | No plan | SEC |
| May 16, 2025 | May 19, 2025 | ADPT | Chief Financial Officer | Form 4 sale | 1,929 | $17k | 0.7% | No plan | SEC |
| Mar 5, 2025 | Mar 6, 2025 | ADPT | Chief Financial Officer | Form 4 sale | 10,320 | $72k | 3.7% | Unusual | SEC |
| Nov 18, 2024 | Nov 19, 2024 | ADPT | Chief Financial Officer | Form 4 sale | 248 | $1k | 0.2% | No plan | SEC |
| Mar 5, 2024 | Mar 6, 2024 | ADPT | Principal Accounting Officer | Form 4 sale | 7,727 | $27k | 5.9% | Unusual | SEC |
| Nov 16, 2023 | Nov 20, 2023 | ADPT | Principal Accounting Officer | Form 4 sale | 259 | $1k | 0.3% | No plan | SEC |
| Mar 6, 2023 | Mar 8, 2023 | ADPT | Principal Accounting Officer | Form 4 sale | 3,529 | $30k | 3.9% | Plan not stated | SEC |
| Nov 16, 2022 | Nov 17, 2022 | ADPT | Principal Accounting Officer | Form 4 sale | 959 | $9k | 2.0% | Plan not stated | SEC |
| Mar 7, 2022 | Mar 8, 2022 | ADPT | Principal Accounting Officer | Form 4 sale | 220 | $3k | 0.5% | Plan not stated | SEC |